ANTI-VEGF DRUGS COMPARED WITH LASER PHOTOCOAGULATION FOR THE TREATMENT OF DIABETIC RETINOPATHY – FUNDING

1. Title: ANTI-VEGF DRUGS COMPARED WITH LASER PHOTOCOAGULATION FOR THE TREATMENT OF DIABETIC RETINOPATHY – FUNDING2. Awarding Authority: National Institute for Health Research (NIHR), GB Email: htafunding@nihr.ac.uk. Web: 3. Contract type: Service contract4. Description: The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this evidence synthesis topic.In order to apply you will need to carefully review the:Commissioning briefStage 1 application supporting informationStage 1 guidance notesApplications received by the advertised closing date will be considered at a first-stage funding committee meeting, and successful applicants will then be invited to submit a stage 2 application. Applicants will have eight weeks to complete and submit their stage 2 application form, which will then be considered at the following HTA funding committee meeting. For more information, please read the commissioning brief.All primary research projects are expected to establish a programme appointed Study Steering Committee and it is important that you read the TSC/SSC Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.5. CPV Code(s): 73110000, 73000000, 73210000, 732200006. NUTS code(s): UKI, UKI3, UKI327. Main site or location of works, main place of delivery or main place of performance: London, Inner London – West, Westminster.8. Reference attributed by awarding authority: 20/799. Estimated value of requirement: Not provided.10. Closes: 23.9.2020 (13:00).11. Address to which they must be sent: For further information regarding the above contract notice please visit:12. Other information: Please visit the website above for documentation# funding opportunity